Search hospitals > Washington > Edmonds
Swedish Cancer Institute-Edmonds
Claim this profileEdmonds, Washington 98026
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Adenocarcinoma
Conducts research for Recurrence
Conducts research for Non-Small Cell Lung Cancer
180 reported clinical trials
6 medical researchers
Summary
Swedish Cancer Institute-Edmonds is a medical facility located in Edmonds, Washington. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Recurrence, Non-Small Cell Lung Cancer and other specialties. Swedish Cancer Institute-Edmonds is involved with conducting 180 clinical trials across 352 conditions. There are 6 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
Top PIs
Alison K. ConlinProvidence Portland Medical Center4 years of reported clinical research
Expert in Cancer
Expert in Breast Cancer
104 reported clinical trials
181 drugs studied
Charles W. DrescherProvidence Portland Medical Center7 years of reported clinical research
Expert in Cancer
Studies Tumors
48 reported clinical trials
97 drugs studied
Nitya AlluriProvidence Portland Medical Center1 year of reported clinical research
Expert in Cancer
Studies Recurrence
28 reported clinical trials
79 drugs studied
Krishna C. AlluriProvidence Portland Medical Center4 years of reported clinical research
Expert in Cancer
Studies Adenocarcinoma
26 reported clinical trials
63 drugs studied
Clinical Trials running at Swedish Cancer Institute-Edmonds
Breast Cancer
Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Bladder Carcinoma
Pancreatic Cancer
Gastric Cancer
Multiple Myeloma
Gallbladder Cancer
Tumors
Radiation and HER2-Targeted Therapy
for Breast Cancer
This Phase III trial compares the recurrence-free interval (RFI) among patients with early-stage, low risk HER2+ breast cancer who undergo breast conserving surgery and receive HER2-directed therapy, and are randomized to not receive adjuvant breast radiotherapy versus those who are randomized to receive adjuvant radiotherapy per the standard of care.
Recruiting2 awards Phase 315 criteria
Chemotherapy + Hormone Therapy
for Breast Cancer
This trial is testing if adding additional cancer-fighting drugs to treatments that stop certain body functions is better than just using the treatments that stop those functions alone. It targets younger women with early-stage breast cancer who have a higher risk of dying from the disease. The treatment works by stopping certain body functions and using drugs to kill cancer cells.
Recruiting2 awards Phase 319 criteria
Durvalumab + Chemotherapy
for Breast Cancer
This phase III trial compares the addition of an immunotherapy drug (durvalumab) to usual chemotherapy versus usual chemotherapy alone in treating patients with MammaPrint Ultrahigh (MP2) stage II-III hormone receptor positive, HER2 negative breast cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as paclitaxel, doxorubicin, and cyclophosphamide work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. There is some evidence from previous clinical trials that people who have a MammaPrint Ultrahigh Risk result may be more likely to respond to chemotherapy and immunotherapy. Adding durvalumab to usual chemotherapy may be able to prevent the cancer from returning for patients with MP2 stage II-III hormone receptor positive, HER2 negative breast cancer.
Recruiting2 awards Phase 340 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Swedish Cancer Institute-Edmonds?
Swedish Cancer Institute-Edmonds is a medical facility located in Edmonds, Washington. This center is recognized for care of Cancer, Breast Cancer, Adenocarcinoma, Recurrence, Non-Small Cell Lung Cancer and other specialties. Swedish Cancer Institute-Edmonds is involved with conducting 180 clinical trials across 352 conditions. There are 6 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.